BioCentury
ARTICLE | Company News

Eden Biodesign, Cancer Research UK deal

September 10, 2007 7:00 AM UTC

CB1954, which is off patent, is in Phase I testing with NAD(P)H dehydrogenase (quinine 2, NQO2) to treat hepatic cell carcinoma (HCC). Cancer Research is conducting that trial for Protherics plc (LS...